Related Experiment Video
Updated: Mar 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Evaluating an Adaptive and Interactive mHealth Smoking Cessation and Medication Adherence Program: A Randomized Pilot
Jennifer B McClure1, Melissa L Anderson, Katharine Bradley
1Group Health Research Institute, Seattle, WA, United States. McClure.J@ghc.org.
The My Mobile Advice Program (MyMAP) demonstrated feasibility and acceptability for smoking cessation. Further research is needed to confirm its effectiveness in helping smokers quit and adhering to medication.
Area of Science:
- Digital Health
- Behavioral Science
- Public Health
Background:
- Mobile health (mHealth) interventions offer scalable solutions for smoking cessation.
- Previous research has not fully established the feasibility, acceptability, or effectiveness of mHealth smoking cessation programs.
Purpose of the Study:
- To assess the feasibility and acceptability of the My Mobile Advice Program (MyMAP).
- To estimate the effects of MyMAP on smoking cessation and medication adherence.
- To inform future research on mHealth smoking cessation interventions.
Main Methods:
- Sixty-six smokers were randomized to either a standard self-help mHealth program or an adaptive, interactive MyMAP program.
- Both groups received a 12-week course of varenicline.
- Feasibility and acceptability were measured through ratings, utilization metrics, and feedback; smoking abstinence and medication adherence were assessed at multiple follow-ups.
Main Results:
- The MyMAP program showed high utilization, with experimental participants logging in significantly more often than controls.
- A majority of experimental participants found MyMAP helpful, easy to use, and would recommend it.
- Smoking abstinence rates were 36% in the experimental group versus 24% in the control group; medication adherence showed no significant difference.
Conclusions:
- The MyMAP intervention is feasible and acceptable for smokers aiming to quit.
- The study was not powered to determine statistical significance in smoking abstinence or medication adherence.
- Results suggest MyMAP warrants further investigation in a larger randomized trial.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017